Ren et al. reported that the overexpression of beta-1,4-galactosyltransferase 1 (B4GALT1) in AML may be linked to poor patient outcomes, and the proportion of Th17 cells shows a positive correlation with B4GALT1 levels [144]. The gene discussed is B4GALT1; the disease is acute myeloid leukemia.